SAM #9154f29be009479383e78306131a3d66

Sole-source bridge contract for Administrative Systems Technology Officer Mission Support Services (ASTO MSS) at NIH

This notice details a sole-source bridge contract for Administrative Systems Technology Officer Mission Support Services (ASTO MSS) at the National Institutes of Health (NIH) Office of the Director. - Sole-source bridge order awarded to General Dynamics Information Technology (GDIT) - Contract supports continuity of mission-support services during IT centralization and transition of the Integrated Data Platform (IDP) to the Center for Information Technology (CIT) - Services cover eight outcome-based objectives: - Operational continuity - Administrative and data modernization - IDP advancement - Governance and lifecycle accountability - Financial stewardship - Enterprise adoption and NIH capability building - Security, privacy, accessibility, and responsible AI compliance - Continuous improvement and transition - Estimated contract ceiling: $7.1M for six-month base period; $15.9M including six-month option - Period of performance: six-month base (Sept 16, 2026 – Mar 15, 2027), six-month option (Mar 16, 2027 – Sept 15, 2027) - Bridge contract is temporary; NIH intends to compete the successor requirement - No specific products, part numbers, or purchase quantities listed - Emphasis on risk mitigation and uninterrupted service during transition

Description

The National Institutes of Health (NIH), Office of Management (OM), approved a sole-source bridge order to General Dynamics Information Technology (GDIT) for Administrative Systems Technology Officer Mission Support Services (ASTO MSS) under NIH Information Technology Services BPA No. 75N91023A00005. The bridge provides continuity of mission-support services for NIH OM, the Deputy Director for Management, and the Integrated Data Platform while NIH advances information technology centralization activities and completes a competitive successor acquisition.

The action consists of a six-month base period from September 16, 2026, through March 15, 2027, and one six-month option period through September 15, 2027. The sole-source action is authorized under FAR 8.401(b) and the applicable GSA Federal Supply Schedule ordering procedures at GSAR 538.7104-3(b)(1)(i), based on unusual urgency. Conducting a separate competition and contractor transition solely for the interim bridge would create unacceptable delay and risk disruption of ongoing mission-critical services.

This justification is limited to the temporary bridge requirement and does not conclude that other sources are incapable of performing the enduring requirement. NIH market research identified qualified sources and competitive vehicles, and NIH intends to compete the successor requirement.

View original listing